US Bancorp’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

US Bancorp’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.9M	Buy	908,163 +39,641	+5%	+$999K	0.03%	297
2026 Q1	$21.9M	Buy	868,522 +102,487	+13%	+$2.61M	0.03%	293
2025 Q4	$19.6M	Buy	766,035 +52,457	+7%	+$1.34M	0.02%	323
2025 Q3	$18.3M	Sell	713,578 -44,829	-6%	-$1.14M	0.02%	341
2025 Q2	$19.2M	Buy	758,407 +108,230	+17%	+$2.69M	0.02%	326
2025 Q1	$16.2M	Buy	650,177 +81,239	+14%	+$2.01M	0.02%	348
2024 Q4	$14M	Sell	568,938 -12,928	-2%	-$324K	0.02%	377
2024 Q3	$15M	Buy	581,866 +308,620	+113%	+$7.79M	0.02%	369
2024 Q2	$6.71M	Buy	273,246 +123,921	+83%	+$3.03M	0.01%	507
2024 Q1	$3.7M	Buy	+149,325	New	+$3.7M	0.01%	653

Other funds holding IBDX

ACA

Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

US Bancorp's IBDX Position: Q2 2026 in Review

US Bancorp increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 4.6% in Q2 2026, buying an estimated $999K and bringing the position to 908,163 shares worth $22.9M. The position accounts for 0.03% of the portfolio, ranked #297.

US Bancorp first reported a position in IBDX in Q1 2024 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

US Bancorp held 908,163 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $22.9M as of Q2 2026.
US Bancorp bought 39,641 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $999K.
iShares iBonds Dec 2032 Term Corporate ETF made up 0.03% of US Bancorp's portfolio in Q2 2026, its #297 holding.
US Bancorp first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.